NCT00585754View on ClinicalTrials.gov

Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Cocaine DependentAlcohol Dependent
Interventions
DRUG

Guanfacine

1.5mg BID

DRUG

Placebo

placebo

Trial Locations (1)

06519

Yale University School of Medicine: Yale Stress Center, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT00585754 - Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse | Biotech Hunter | Biotech Hunter